The content of this website is intended for healthcare professionals only

Clinical articles

Our clinical articles provide comprehensive overviews of a large range of clinical topics and include helpful key learning points. Log your learning in your PDP tracker to claim CME credits.

For information on our editorial policy, click here.

You are viewing articles 1 - 15 of 713
NICE recommends perfusion technique for use under special arrangements in final guidance; SMC accepts pertuzumab for combination first-line treatment of breast cancer; DDA issues advice for expected supply shortage of Clexane
MHRA issues drug safety update for ipilimumab; NICE publishes new guideline for the assessment and management of renal and ureteric stones; erenumab not recommended for migraine prevention in NICE draft guidance
DHSC issues alert for use of antiviral medicines in cases of influenza; EAMS positive scientific opinion for atezolizumab for lung cancer; NICE recommends benralizumab for severe asthma in final draft guidance
NICE recommends Kymriah within CDF for lymphoblastic leukaemia, Juluca and Briviact recommended in Wales for HIV-1 infection and refractory epilepsy respectively, MHRA issues statement on Allergan
NICE recommends several treatments including Keytruda, within CDF, for melanoma and Vyxeos for acute myeloid leukaemia; EMA review concludes omega-3 is not effective in preventing heart disease
CAR T-cell therapy now recommended for some types of non-Hodgkin lymphoma in final draft guidance, NICE rejects vandetanib for medullary thyroid cancer; SMC accepts pertuzumab for HER2 positive breast cancer
A review of the presentation, diagnosis and management of a condition which can lead to complications such as impaired renal function, renal failure and septicaemia
NICE approves innovative heart procedure in draft recommendations; AWMSG recommends Ivemend® for the prevention of nausea and vomiting
A review of the presentation and management of this highly contagious condition transmitted by prolonged direct skin to skin contact
NICE recommends tofacitinib for ulcerative colitis and regorafenib for liver cancer; Royal College of Surgeons issues guidance to help manage winter pressures
Pembrolizumab recommended as adjuvant therapy for melanoma and combination therapy for lung cancer in final NICE draft guidance; thrombectomy to be offered up to 24 hours after onset of stroke
A review of new evidence around management and how this can guide current consultations with hypertensive patients ahead of NICE’s upcoming guidance update
CAR T-cell therapy recommended for leukaemia, and lenvatinib for hepatocellular carcinoma; drug safety update on hydrochlorothiazide due to risk of non-melanoma skin cancer
Vyxeos recommended for acute myeloid leukaemia in NICE final draft guidance; heavy menstrual bleeding NICE guideline updated; cannabis-based products: guidance and information on law
A review of the inhaled long-acting bronchodilators for COPD
Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470
Twitter Facebook
A Wilmington Company